Quality of Life in Brain Tumor Patients: The Relative Contributions of Depression, Fatigue, Emotional Distress, and Existential Issues
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Neuropsychiatric problems, and how they interact to impact on quality of life (QOL) in brain tumor patients, are generally poorly understood. The objectives of this study were: (1) to document the prevalence of depression, fatigue, emotional distress, and existential issues in a sample of brain tumor patients (2) to examine the interconnectedness of these problems, and (3) to explore their relationship with disease-related variables and QOL. This is a cross-sectional, questionnaire-based survey of 73 patients with primary brain tumors who presented to a neurological clinic at a tertiary cancer centre for ongoing care. Data for 60 participants (29 women, 31 men) who completed validated questionnaires were retained for analysis. Results showed that there was a high burden of depressive symptoms as measured by the Beck Depression Inventory-II (mean score 11.1, SD 7.4), with 38% of the sample scoring in the clinically depressed range. Overall QOL scores for this sample were similar to a reference sample of brain tumor patients. The scores on the existential subscale of the McGill Quality of Life questionnaire were comparable to those of a reference sample of cancer patients receiving ongoing care (mean score 7.2; SD 1.7). Fifty per cent of the sample could be classified as struggling with existential issues. Although scores reflecting depression, fatigue, emotional distress, and existential problems were interrelated, the presence of depressive symptoms was the single most import…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“prevalence rates of existential distress in patients with terminal cancer vary from 3 to 29%, depending on the operationalization of the concept”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Pelletier et al., 2002
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · cited 4×
“Overall, the results obtained by the patients in this study do not differ significantly from those obtained by FACT-BR normative sample [25] or from the scores obtained by the normative sample for the FACT-G [33] (none of the t-tests were significant) (Table 3).”
MethodResultInfluentialThe Psychology of Religion and Coping: Theory Research Practice
Barrett, J. L., & Pargament, K. I. (1998) · Review of Religious Research · doi:10.2307/3512468 · Cited by 2,610
The Psychology of Religion and Coping
McFadden, S. H., & Pargament, K. I. (1998) · Journal for the Scientific Study of Religion · doi:10.2307/1387534 · Cited by 1,441
Decision making during serious illness: What role do patients really want to play?
Degner, L. F., & Sloan, J. A. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90110-9 · Cited by 1,008 · cited 3×
“Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues Guy Pelletier1, Marja J. Verhoef2, Nasreen Khatri3 and Neil Hagen4,5,6 1Department of Psychosocial Resources, Tom Baker Cancer Centre, 2Department of Community Health Sciences, 3Depart…”
MethodInfluentialFine, H. A., Dear, K. B. G., Loeffler, J. S., Mc Black, P. L., & Canellos, G. P. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2585::aid-cncr2820710825>3.0.co;2-s · Cited by 864 · cited 1×
“For example, even with aggressive radiation and chemotherapy regimes, the median survival for patients with grade 4 astrocytoma (glioblastoma multiforme or GBM) is about 12 months, and for grade 3 gliomas it is about 36 months [4].”
BackgroundA case for including spirituality in quality of life measurement in oncology
Brady, M. J., Peterman, A. H., Fitchett, G., Mo, M., & Cella, D. (1999) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199909/10)8:5<417::aid-pon398>3.0.co;2-4 · Cited by 835 · cited 1×
“[20] found that spirituality as measured by the functional assessment of chronic illness therapyspirituality (FACIT-Sp) correlated with general QOL to the same extent as physical well-being.”
BackgroundCohen, S. R., Mount, B. M., Strobel, M. G., & Bui, F. (1995) · Palliative Medicine · doi:10.1177/026921639500900306 · Cited by 738 · cited 9×
“This 7-item subscale is part of the MQOL, a multidimensional QOL questionnaire designed for use at all phases of the disease trajectory in patients with life-threatening diseases.”
MethodInfluentialPsychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.
Arnau, R. C., Meagher, M. W., Norris, M. P., & Bramson, R. (2001) · Health Psychology · doi:10.1037/0278-6133.20.2.112 · Cited by 694 · cited 1×
“A recent study demonstrated the validity and the usefulness of the BDI-II in the detection of depression in primary care medical patients [27].”
BackgroundComorbid depression and anxiety spectrum disorders
Gorman, J. M. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:4<160::aid-da2>3.0.co;2-j · Cited by 630
Robin Cohen, S., Mount, B. M., Bruera, E., Provost, M., Rowe, J., & Tong, K. (1997) · Palliative Medicine · doi:10.1177/026921639701100102 · Cited by 436 · cited 1×
“The MQOL has been applied in patients with advanced cancer [29] and in patients with HIV [30].”
MethodCohen, S. R., Mount, B. M., Tomas, J. J. N., & Mount, L. F. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960201)77:3<576::aid-cncr22>3.0.co;2-0 · Cited by 410 · cited 10×
“This 7-item subscale is part of the MQOL, a multidimensional QOL questionnaire designed for use at all phases of the disease trajectory in patients with life-threatening diseases.”
BackgroundMethodInfluentialMethylphenidate therapy improves cognition, mood, and function of brain tumor patients.
Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2522 · Cited by 377 · cited 1×
“Although for many brain tumor patients, treating depression with psychotherapy may present a welcome relief from the use of medications, those who also experience significant fatigue or who may have limitations preventing them from benefiting from psychotherapy may do better with antidepressant medication or with psyc…”
BackgroundOsoba, D., Aaronson, N. K., Muller, M., Sneeuw, K., Hsu, M. A., Yung, W. K. A., Brada, M., & Newlands, E. (1996) · Quality of Life Research · doi:10.1007/bf00435979 · Cited by 343 · cited 1×
“It is difficult to predict the main causes of fatigue because there were several contributing factors for fatigue in the study sample, including medical (effects of the illness and treatment, other co-morbid physical disorders) [ 37 ], psychological (depression and existential) and other factors.”
BackgroundFehring, R. J., Miller, J. F., & Shaw, C. (1997) · PubMed · Cited by 321
Taphoorn, M. J. B., Schiphorst, A. K., Snoek, F. J., Lindeboom, J., Wolbers, J. G., Karim, A. B. M. F., Huijgens, P. C., & Heimans, J. J. (1994) · Annals of Neurology · doi:10.1002/ana.410360111 · Cited by 303 · cited 1×
“Frequently reported neuropsychiatric problems in brain tumor patients include delirium, dementia, depression, anxiety, fatigue, somnolence and disinhibition disorders including restlessness, mania, and aggression [2,7,8].”
BackgroundKiebert, G. M., Curran, D., Aaronson, N. K., Bolla, M., Menten, J., Rutten, E. H. J. M., Nordman, E., Silvestre, M. E., Pierart, M., & Karim, A. B. M. F. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00268-8 · Cited by 256
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study
Scott, J. N., Rewcastle, N. B., Brasher, P. M. A., Fulton, D. S., MacKinnon, J. A., Hamilton, M. G., Cairncross, J. G., & Forsyth, P. A. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<183::aid-ana7>3.0.co;2-7 · Cited by 250 · cited 1×
“Malignant gliomas are considered incurable; less than 2% of GBM patients survive 3 years or more [5].”
BackgroundSpiritual Well‐Being, Religiousness and Hope Among Women With Breast Cancer
Mickley, J. R., Soeken, K., & Belcher, A. (1992) · Image: the Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.1992.tb00732.x · Cited by 215 · cited 1×
“Other research [22–24] showed an association among the extent of religious practice, existential distress, and negative mood states in cancer patients.”
BackgroundSpiritual Well-Being and Anxiety in Adults Diagnosed with Cancer
Kaczorowski, J. M. (1989) · The Hospice Journal · doi:10.1080/0742-969x.1989.11882658 · Cited by 196 · cited 1×
“Other research [22–24] showed an association among the extent of religious practice, existential distress, and negative mood states in cancer patients.”
BackgroundAnxiety and depression in patients with an intracranial neoplasm before and after tumour surgery
PRINGLE, A.-M., TAYLOR, R., & WHITTLE, I. R. (1999) · British Journal of Neurosurgery · doi:10.1080/02688699944177 · Cited by 166
Neuropsychiatric aspects of traumatic brain injury
Arciniegas, D. B., Topkoff, J., & Silver, J. M. (2000) · Current Treatment Options in Neurology · doi:10.1007/s11940-000-0017-y · Cited by 164 · cited 2×
“Our knowledge of the effectiveness of psychotherapy for depression in brain tumor patients or other neurologically impaired populations remains limited, but cognitive behavior therapy has been identified as worthy of additional investigation [43,44].”
BackgroundMackworth, N. H., Fobair, P., & Prados, M. (1992) · Journal of Neuro-Oncology · doi:10.1007/bf00172600 · Cited by 162 · cited 1×
“Frequently reported neuropsychiatric problems in brain tumor patients include delirium, dementia, depression, anxiety, fatigue, somnolence and disinhibition disorders including restlessness, mania, and aggression [2,7,8].”
BackgroundRe-creating your life: a spiritual/psychotherapeutic intervention for people diagnosed with cancer
Cole, B., & Pargament, K. (1999) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199909/10)8:5<395::aid-pon408>3.0.co;2-b · Cited by 160 · cited 1×
“Similarly, brain tumor patients may benefit from recently developed pastoral or psychotherapeutic interventions designed to help people come to terms with existential and spiritual concerns [48,49].”
BackgroundCognitive Functioning and Quality of Life in Malignant Glioma Patients: A Review of the Literature
Weitzner, M. A., & Meyers, C. A. (1997) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199709)6:3<169::aid-pon269>3.0.co;2-# · Cited by 134 · cited 1×
“, fatigue, cognitive problems); and lastly, side effects of treatment regimens for brain tumors, including chemotherapy, radiation therapy, and other interventions [37–39].”
BackgroundPsychological management of post‐stroke depression
Kneebone, I. I., & Dunmore, E. (2000) · British Journal of Clinical Psychology · doi:10.1348/014466500163103 · Cited by 127 · cited 1×
“Our knowledge of the effectiveness of psychotherapy for depression in brain tumor patients or other neurologically impaired populations remains limited, but cognitive behavior therapy has been identified as worthy of additional investigation [43,44].”
BackgroundArmstrong, C. L., Ruffer, J. E., Corn, B. W., DeVries, K., & Mollman, J. E. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2263 · Cited by 124 · cited 1×
“While some questionnairebased studies identify fatigue as prevalent following chemotherapy or radiation therapy [14–16], others using a reliable measure of fatigue in a study of patients with low-grade glioma, did not find a difference in levels of fatigue between the patients and the ‘normal population’ [17].”
ResultInfluentialQuality of life in HIV disease as measured by the McGill Quality of Life Questionnaire
Cohen, S. R., Hassan, S. A., Lapointe, B. J., & Mount, B. M. (1996) · AIDS · doi:10.1097/00002030-199610000-00016 · Cited by 124 · cited 1×
“The MQOL has been applied in patients with advanced cancer [29] and in patients with HIV [30].”
MethodSadi, M. V., & Barrack, E. R. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2574::aid-cncr2820710823>3.0.co;2-1 · Cited by 115
Somnolence syndrome in adults following cranial irradiation for primary brain tumours
Faithfull, S., & Brada, M. (1998) · Clinical Oncology · doi:10.1016/s0936-6555(98)80011-3 · Cited by 110 · cited 1×
“Detailed observations of 19 brain tumor patients led Faithful and Brada [13] to the identification of a somnolence syndrome that follows treatment.”
BackgroundQuality of life in brain tumor patients
Gıovagnolı, A. R., Tamburini, M., & Boiardi, A. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00177445 · Cited by 106
Psychosocial and Neuropsychiatric Aspects of Patients with Primary Brain Tumors
Weitzner, M. A. (1999) · Cancer Investigation · doi:10.3109/07357909909040599 · Cited by 101 · cited 1×
“Neuropsychiatric problems in brain tumor patients can arise from the disease process itself, which usually causes focal neurological damage and from radiation therapy and chemotherapy which can cause more diffuse damage [6].”
BackgroundRelationship between fatigue and quality of life in patients with glioblastoma multiformae.
Lovely, M., Miaskowski, C. A., & Dodd, M. J. (1999) · PubMed · Cited by 98
Alternative therapy use in neurologic diseases: Use in brain tumor patients
Verhoef, M. J., Hagen, N. A., Pelletier, G., & Forsyth, P. A. (1999) · Neurology · doi:10.1212/wnl.52.3.617 · Cited by 79 · cited 1×
“Finally, the participants were asked to answer four questions on their use of complementary therapies that were similar to those used in a previous study in this clinic [32].”
ResultSelf-citationBrain Tumor as a Threat to Life and Personality: The Spouse's Perspective
Salander, P. (1996) · Journal of Psychosocial Oncology · doi:10.1300/j077v14n03_01 · Cited by 65 · cited 1×
“Malignant brain tumors usually result in devastating morbidity for those affected and for their families and typically result in death of the patient within a few years or less [1–3].”
BackgroundRecording neurological impairment in clinical trials of glioma
Grant, R., Slattery, J. M. A., Gregor, A., & Whittle, I. R. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01051047 · Cited by 62 · cited 1×
“9% to 39% [9–12].”
Brain tumor support group: content themes and mechanisms of support.
Leavitt, M., Lamb, S. A., & Voss, B. S. (1996) · PubMed · Cited by 49
Quality of life of brain tumor patients
Lovely, M. (1998) · Seminars in Oncology Nursing · doi:10.1016/s0749-2081(98)80045-4 · Cited by 36 · cited 1×
“9% to 39% [9–12].”
The severity of major depression and choice of treatment in primary care practice.
Schulberg, H. C., Pilkonis, P. A., & Houck, P. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.66.6.932 · Cited by 36 · cited 1×
“Antidepressant medications and psychotherapy (particularly cognitive behavior therapy) have been shown to be of comparable effectiveness in the treatment of major depression, although the studies available so far have been conducted mostly with populations from which major depression with psychotic features or problem…”
ResultDepression in the medically ill: Management considerations
Evans, D. L., Staab, J., Ward, H., Leserman, J., Perkins, D. O., Golden, R. N., & Petitto, J. M. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:4<199::aid-da6>3.0.co;2-a · Cited by 36
Relationships: importance for patients with cerebral tumours
Kaplan, M. E. M. C. P. (2000) · Brain Injury · doi:10.1080/026990500120727 · Cited by 35 · cited 1×
“The first version of the BDI has been used previously in research with brain tumor patients [11].”
MethodTHE ROLE OF PSYCHOTHERAPY IN TREATING PSYCHIATRIC DISORDERS
Craighead, W. E., & Craighead, L. W. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70332-1 · Cited by 31 · cited 1×
“Antidepressant medications and psychotherapy (particularly cognitive behavior therapy) have been shown to be of comparable effectiveness in the treatment of major depression, although the studies available so far have been conducted mostly with populations from which major depression with psychotic features or problem…”
ResultQuality-of-life issues in patients with malignant gliomas.
Aiken, R. D. (1994) · PubMed · Cited by 31
Community Integration Questionnaire for Patients with Brain Tumor: A Comparative Study
Kaplan, C. P. (2000) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-200005000-00005 · Cited by 18 · cited 1×
“, fatigue, cognitive problems); and lastly, side effects of treatment regimens for brain tumors, including chemotherapy, radiation therapy, and other interventions [37–39].”
BackgroundShinoda, J., Sakai, N., Hara, A., Ueda, T., Sakai, H., & Nakatani, K. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005816320920 · Cited by 13
Psychiatric and Psychosocial Aspects of Neurooncology
Passik, S. D., Malkin, M. G., BREITBART, W. S., & Horowitz, S. A. (1994) · Journal of Psychosocial Oncology · doi:10.1300/j077v12n01_06 · Cited by 12 · cited 1×
“Malignant brain tumors usually result in devastating morbidity for those affected and for their families and typically result in death of the patient within a few years or less [1–3].”
Background(2000) · Pure Amsterdam UMC · doi:10.1002/1097-0142(20001015)89:8
(1999) · doi:10.1002/(sici)1099-1611(199907/08)8:4<315::aid-pon391>3.0.co;2-g · cited 1×
“Comparatively, the point prevalence rate for depression in the general adult population is approximately 6% [34]; 15–30% of individuals with major medical conditions develop a depressive disorder at some time during the course of their physical illness [34,35], and an estimated 6–15% of cancer patients can be expected…”
Background(1995) · doi:10.1002/1097-0142(19950301)75:5<1151::aid-cncr2820750515>3.0.co;2-q · cited 14×
“%) of the participants reported a score of 0 or 1 on question 1 of the FACT-BR, indicating that they felt that their energy was ‘quite a bit low’ or ‘very low’.”
MethodResultInfluentialHolland (1999) · doi:10.1002/(sici)1099-1611(199901/02)8:1<14::aid-pon321>3.0.co;2-e · cited 1×
“[21], in a study of religious and spiritual beliefs in melanoma patients, found that their measure of spirituality correlated with neither QOL nor emotional distress.”
Background
Research works printed but not linked: 3
- Beck A, Steer RA, Brown GK: Manual for the Beck Depression Inventory-II. The Psychological Corporation, New York, 1996
- Craighead WE, Craighead L, Ilardi SS: Psychosocial treatments for major depressive disorder. In: Nathan PE, Gorman JM (eds) A Guide to Treatments that Work. Oxford University Press, New York, 1998, pp 226-239
- Simpson S: Management of depression in cancer patients. Perspectives in Depression 8: 1-5, 2000
Cited by
(2020) · doi:10.1056/nejmra1907805 · Cited by 634
Incidence of Suicide in Persons With Cancer
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8941 · Cited by 608
Comorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
Mitchell, A. J., Benito-León, J., González, J.-M. M., & Rivera-Navarro, J. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70166-6 · Cited by 519
Psychiatric disorders in advanced cancer
Miovic, M., & Block, S. (2007) · Cancer · doi:10.1002/cncr.22980 · Cited by 376
“Depression is associated with decreased adherence to treatment, prolonged hospital stays, and reduced quality of life.(45,46) It is a major risk factor for desire to hasten death,(9,47,48) and as many as 59% of terminally ill patients who request assisted suicide are depressed.”
Background
Metadata
- Authors
- Pelletier, G., Verhoef, M. J., Khatri, N., & Hagen, N.
- Affiliations
- University of Calgary (CA)
- ORCID
- Hagen, Neil
- Venue
- Journal of Neuro-Oncology
- Published
- 2002-03
- Volume
- 57
- Issue
- 1
- Pages
- 41-49
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W1574260815
- Cited by
- 362
- References
- 49
- Citations by year
- 2026: 8 · 2025: 2 · 2024: 17 · 2023: 9 · 2022: 18 · 2021: 13 · 2020: 23 · 2019: 16 · 2018: 26 · 2017: 24 · 2016: 21 · 2015: 28 · 2014: 12 · 2013: 19 · 2012: 20
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Journal of Neuro-Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Owens Foundation
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- quality of life, brain tumors, depression, fatigue, emotional distress, existential questions, neuropsychiatric symptoms, primary brain tumors, prevalence of depressive symptoms, McGill Quality of Life Questionnaire, predictors of quality of life
- MeSH terms
- Adult, Affective Symptoms, Brain Neoplasms, Depression, Fatigue, Female, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Regression Analysis, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.